Bullous pemphigoid in infancy developing after the first vaccination.
Department of Dermatology, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK. juber.hafiji@addenbrookes.nhs.uk
J
J
Hafiji
B
B
Bhogal
E
E
Rytina
N P
NP
Burrows
D004165:Diphtheria / Q000517:prevention & control; D005938:Glucocorticoids / Q000627:therapeutic use*; D006192:Haemophilus Infections / Q000517:prevention & control; D000069443:Heptavalent Pneumococcal Conjugate Vaccine; D006801:Humans; D007223:Infant; D008297:Male; D010391:Pemphigoid, Bullous / Q000139:chemically induced / Q000188:drug therapy; D011008:Pneumococcal Infections / Q000517:prevention & control; D022242:Pneumococcal Vaccines / Q000009:adverse effects; D011051:Poliomyelitis / Q000517:prevention & control; D011239:Prednisolone / Q000627:therapeutic use*; D013742:Tetanus / Q000517:prevention & control; D014611:Vaccination / Q000009:adverse effects*; D014917:Whooping Cough / Q000517:prevention & control
D005938:Glucocorticoids; D000069443:Heptavalent Pneumococcal Conjugate Vaccine; D022242:Pneumococcal Vaccines; D011239:Prednisolone